239 related articles for article (PubMed ID: 9285495)
1. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.
Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H
Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495
[TBL] [Abstract][Full Text] [Related]
2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
3. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
[TBL] [Abstract][Full Text] [Related]
4. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease.
Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
Exp Clin Endocrinol Diabetes; 1999; 107(1):21-8. PubMed ID: 10077351
[TBL] [Abstract][Full Text] [Related]
5. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
[TBL] [Abstract][Full Text] [Related]
6. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
7. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
Boulton M; Gregor Z; McLeod D; Charteris D; Jarvis-Evans J; Moriarty P; Khaliq A; Foreman D; Allamby D; Bardsley B
Br J Ophthalmol; 1997 Mar; 81(3):228-33. PubMed ID: 9135388
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy.
Hirase K; Ikeda T; Sotozono C; Nishida K; Sawa H; Kinoshita S
Arch Ophthalmol; 1998 Jun; 116(6):738-41. PubMed ID: 9639441
[TBL] [Abstract][Full Text] [Related]
10. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
[TBL] [Abstract][Full Text] [Related]
11. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients.
Frystyk J; Bek T; Flyvbjerg A; Skjaerbaek C; Ørskov H
Diabet Med; 2003 Apr; 20(4):269-76. PubMed ID: 12675639
[TBL] [Abstract][Full Text] [Related]
13. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
14. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.
Grant M; Russell B; Fitzgerald C; Merimee TJ
Diabetes; 1986 Apr; 35(4):416-20. PubMed ID: 2420665
[TBL] [Abstract][Full Text] [Related]
16. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics.
Waldbillig RJ; Jones BE; Schoen TJ; Moshayedi P; Heidersbach S; Bitar MS; van Kuijk FJ; de Juan E; Kador P; Chader GJ
Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030
[TBL] [Abstract][Full Text] [Related]
17. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
[TBL] [Abstract][Full Text] [Related]
19. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
20. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
Simó R; Carrasco E; García-Ramírez M; Hernández C
Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
